{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-22-000348","form_type":"8-K","ticker":"BICX","cik":"0001443863","company_name":"BioCorRx Inc.","filed_at":"2022-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.505254+00:00","generated_at":"2026-06-27T17:10:20.768523+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioCorRx raises $1M via private placement of 229,886 shares at $4.35/share to two directors","bullets":["Gross proceeds of $1M from sale of 229,886 shares at $4.35 per share to Lucido and Galligan trusts.","Both investors are BioCorRx board members; Louis Lucido and Joseph Galligan are the trustees.","Use of proceeds: 48% for legal fees from Buchalter; 52% for general working capital and administration.","Agreements became effective on January 12 (Lucido) and January 19 (Galligan) upon cash payment.","Shares are restricted securities issued under Rule 506 of Regulation D and bear appropriate legends."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-22-000348","json":"https://secwatch.observer/filing/0001477932-22-000348.json","markdown":"https://secwatch.observer/filing/0001477932-22-000348.md","text":"https://secwatch.observer/filing/0001477932-22-000348.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222000348/0001477932-22-000348-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222000348/bicx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T17:10:20.768523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}